Pharma Journalist 8769 posts 0 comments

Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European Commission has approved a new indication for DARZALEX (daratumumab) subcutaneous (SC)…
Read More...

A new potential treatment for generalised myasthenia gravis (gMG), a rare and debilitating autoimmune neuromuscular disease, has shown promising results in a large international…
Read More...

Biotech company Kling Bio has announced a new collaboration and license option agreement with global pharmaceutical giant Sanofi aimed at accelerating the discovery of neutralizing…
Read More...

Sutro Biopharma, Inc., a company specializing in next-generation antibody drug conjugates (ADCs), has announced a new collaboration with the U.S. Food and Drug Administration (FDA) to…
Read More...

Sanofi has announced an agreement to acquire London-based biotechnology company Vicebio Ltd, expanding its presence in the respiratory vaccine space. The deal brings with it a promising…
Read More...

ProMIS Neurosciences announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead Alzheimer’s disease (AD) therapeutic candidate, PMN310.…
Read More...

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. have announced that China’s Center for Drug Evaluation (CDE) has approved their lead candidate, AHB-137, to proceed into a…
Read More...

Sarepta Therapeutics, a leader in precision genetic medicine for rare diseases, announced it has voluntarily and temporarily halted all shipments of ELEVIDYS (delandistrogene…
Read More...

Johnson & Johnson has officially submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for icotrokinra, an investigational first-in-class…
Read More...

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected…
Read More...